TrueBlue (NYSE:TBI – Get Free Report) released its quarterly earnings data on Wednesday. The business services provider reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.14, Zacks reports. The company had revenue of $385.95 million during the quarter, compared to the consensus estimate of $385.04 million. TrueBlue had a negative return on equity of 3.75% and a negative net margin of 8.02%. TrueBlue updated its Q1 2025 guidance to EPS.
TrueBlue Price Performance
Shares of NYSE TBI opened at $6.39 on Friday. The stock has a market cap of $188.80 million, a PE ratio of -1.54, a price-to-earnings-growth ratio of 3.55 and a beta of 1.42. The firm has a fifty day moving average price of $7.92 and a 200-day moving average price of $7.77. TrueBlue has a 1 year low of $6.20 and a 1 year high of $12.88.
Analyst Ratings Changes
A number of brokerages recently weighed in on TBI. StockNews.com upgraded shares of TrueBlue from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. BMO Capital Markets dropped their target price on TrueBlue from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.
TrueBlue Company Profile
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Featured Articles
- Five stocks we like better than TrueBlue
- Learn Technical Analysis Skills to Master the Stock Market
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Gold’s Ascent: Can Miners and ETFs Take Investors to $3,000?
- What is MarketRank™? How to Use it
- Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Receive News & Ratings for TrueBlue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue and related companies with MarketBeat.com's FREE daily email newsletter.